# Clarivius — Comprehensive Clinical, Architectural & Regulatory Knowledge Base

> Clarivius (https://clarivius.com/)
> Slogan: The Pathway to Clinical Clarity / Vaše cesta ke klinickému vyřešení / Der Weg zur klinischen Klarheit
> Mission: "No complex case stays unprecedented simply because the right specialist is not here right now."
> Hosting: European Union (Frankfurt / Prague) · GDPR Art. 6 & Art. 9 Compliant Dual-Track Architecture

---

## 1. Executive Summary & Category Definition

Clarivius is a Global Clinical Consultation Platform and Specialist Precedent Network. Unlike consumer symptom-checkers or generic hospital directories, Clarivius solves a fundamental market failure in complex medicine: when a treating physician or patient encounters an atypical, ultra-rare, or anatomically obscure pathology, local medical teams frequently reach a diagnostic or therapeutic deadlock simply because no local clinician has encountered that specific presentation before.

Clarivius bridges this gap through a searchable Global Specialist Precedent Index coupled with two purpose-built, architecturally isolated clinical pathways:
1. **Clarivius Peer (Doctor-to-Doctor)**: A zero-PII consultation workflow for hospital physicians and clinical departments to consult verified international peers in under 90 seconds.
2. **Clarivius Direct (Patient-to-Specialist)**: A consent-backed second-opinion and DICOM cross-sectional imaging review service for patients navigating complex diagnostic odysseys.

---

## 2. Platform Architecture & Three Pillars

### Pillar 1: Global Specialist Precedent Index
- **Mechanism**: Rather than indexing physicians by static department titles or administrative ranks, the Clarivius Precedent Engine indexes verified clinicians by documented procedural experience, rare surgical series, published cross-sectional imaging protocols, and verified collegial endorsements.
- **Scope**: Covers pathologies that fall outside all 24 European Reference Networks (ERNs) as well as complex multi-specialty border cases (e.g., urogenital-proctological fistulas, pelvic floor anomalies, retroperitoneal entrapment).

### Pillar 2: Clarivius Peer — Anonymised Doctor-to-Doctor Consultation
- **Intake**: Treating physicians submit cases structured into exactly 4 clinical fields:
  1. Age (years)
  2. Sex (biological sex)
  3. BMI (kg/m²)
  4. De-identified Clinical Narrative (symptoms, diagnostic timeline, lab findings, imaging descriptors)
- **Zero-PII Compliance Gate**: Automated client- and server-side privacy filters scan the clinical text in real time. If personal identifiers (patient names, DOBs, national IDs, hospital record numbers, phone numbers, email addresses) are detected, matching is immediately suspended until the input is sanitized.
- **Workflow**:
  1. 90-Second Structured Case Intake
  2. Precedent Matching & Sub-Specialist Ranking
  3. Collegial Case Exchange & Signed Summary Delivery
  4. Clinical Governance: Clinical responsibility remains 100% with the patient's local treating physician.

### Pillar 3: Clarivius Direct — Consented Patient-to-Specialist Review
- **Intake**: Designed for patients with chronic, relapsing, or unresolved symptoms. Patients upload full chronological medical records and uncompressed cross-sectional DICOM imaging (3T Pelvic MRI, CT, endoscopic video) into an isolated European Union vault under explicit GDPR Art. 6(1)(a) and Art. 9(2)(a) consent.
- **Specialist Match**: Matches the complete dossier with an international sub-specialist who has published on or operated on that specific anatomical condition.
- **Deliverable**: Comprehensive written specialist consultation report plus a structured **Treating-Physician Handover Brief** designed to facilitate collaborative care with the patient's local surgical team.

---

## 3. Founding Clinical Case Study: The 18-Month Diagnostic Odyssey

### Clinical Summary
Clarivius was founded following an 18-month diagnostic journey involving 18 physicians across 5 medical disciplines (General Surgery, Proctology, Urology, Radiology, and Microbiology). The patient suffered from an ultra-rare adult presentation of an imperforate/ruptured Cowper's gland syringocele and perineal fistula that eluded standard diagnostic protocols.

### Key Metrics
- 18 Doctors consulted across regional and university hospital departments.
- 18 Months elapsed from initial perineal mass to definitive surgical indication.
- 5 Specialties involved without reaching diagnostic synthesis.
- 0 of 24 European Reference Networks cover this accessory urogenital gland pathology.
- < 72 Hours target match time via the Clarivius Precedent Index to European reconstructive urology centers.

### 5-Stage Chronological Breakdown

#### Stage 1 (Months 1–2): Initial Perineal Mass & Early Misdiagnoses
- **Presentation**: Adult male presents with a painful, mobile 1.5 × 1.0 cm perineal lump near the left pubic ramus without systemic fever (37.2 °C).
- **Misdiagnoses**:
  - Outpatient Surgery initially diagnoses a cutaneous furuncle/abscess (ICD-10 L023) and prescribes topical ichthammol.
  - Pain recurs specifically following ejaculation; Surgery re-classifies the mass as an unspecified benign perineal neoplasm (ICD-10 D235).
- **Diagnostics**: Scrotal and perineal ultrasound identifies a 7 mm anechoic fluid collection near the external anal sphincter. A 1.5T Pelvic MRI reports a 47 mm transsphincteric perianal fistula opening at 1 o'clock.
- **Clinical Blind Spot #1 (The Compartment Trap)**: Triage defaulted to proctology because the tract emerged on the posterior perineum, missing the post-ejaculatory symptom trigger that signaled an accessory male reproductive gland.

#### Stage 2 (Months 3–7): Proctological Laser Ablation (FiLaC) & Mucoprotein Relapse
- **Intervention**: Specialized Proctology performs surgical abscess extirpation and Fistula-tract Laser Closure (FiLaC) under analgosedation in Month 3.
- **Relapse**: Radial laser energy successfully sealed the distal posterior exit tract in the perianal subcutaneous tissue, but left the upstream secretory gland in the deep perineal pouch untouched. By Month 7, the tract ruptured with recurrent clear mucoprotein discharge.
- **Pathophysiological Mechanism**: During sexual arousal and bulbospongiosus contraction, intraductal secretory pressure in the bulbourethral gland reaches 200–500 cm H2O. Sealing the skin exit without decompressing or extirpating the ruptured gland guarantees high-pressure re-dissection of the perineal tissue planes.

#### Stage 3 (Months 8–11): Multi-Departmental Deadlock (False-Negative UCG & CT)
- **Deadlock**: General Surgery, Urology, and Proctology enter a multi-month standstill. Repeated pelvic CT scans fail to visualize small soft-tissue tracts in the urogenital diaphragm.
- **Urethrography Flaw**: Retrograde urethrography (UCG/VCUG) is reported as normal.
- **Clinical Blind Spot #2 (The Retrograde Valve Mechanism)**: During retrograde urethrography, positive intraluminal contrast pressure inside the bulbar urethra compresses the oblique bulbourethral duct orifice against the urethral floor like a one-way flap valve. Contrast cannot enter the gland lumen, producing a false-negative study.

#### Stage 4 (Months 11–12): High-Resolution 3T Pelvic MRI Breakthrough
- **Protocol**: High-resolution 3T multi-planar Pelvic MRI utilizing dedicated thin-slice (3 mm) T2-weighted turbo spin-echo (TSE) and fat-suppressed Short Tau Inversion Recovery (STIR) sequences without endorectal coil.
- **Findings**: Direct visualization of a hyperintense, mucin-filled 12 × 8 mm cystic formation within the right bulbourethral gland (Cowper's gland, glandula bulbourethralis) in the deep perineal space (spatium perinei profundum). A narrow fistulous tract is traced coursing inferoposteriorly between the bulbospongiosus muscle and the external anal sphincter.

#### Stage 5 (Months 13–18): Definitive Reconstructive Indication & Precedent Matching
- **Synthesis**: Synthesis between high-field 3T imaging and clinical symptom kinetics confirms an adult Cowper's gland syringocele with secondary perineal fistulization.
- **Treatment Options Identified via European Specialist Precedent**:
  1. Endoscopic Holmium:YAG laser marsupialization / deroofing of the syringocele via transurethral approach (decompresses high-pressure secretory volume).
  2. Open transperineal bulbourethral extirpation with excision of the fistulous tract for chronic fibrotic presentations.
- **Impact**: Clarivius extracts this exact clinical trajectory to ensure future clinicians and patients connect with verified reconstructive urologists in days, not 18 months.

---

## 4. Technical & GDPR Data Isolation Matrix

Clarivius enforces physical, logical, and cryptographic separation between anonymised peer consultations and identifiable patient dossiers:

| Architectural Dimension | Clarivius Peer (Doctor-to-Doctor) | Clarivius Direct (Patient-to-Specialist) |
| :--- | :--- | :--- |
| **Legal Basis & GDPR** | Anonymised health data (outside GDPR Art. 4(1) scope; zero patient PII). | Explicit per-consultation informed consent under GDPR Art. 6(1)(a) and Art. 9(2)(a). |
| **Permitted Clinical Fields** | Exactly 4 fields: Age, Sex, BMI, de-identified clinical narrative. Zero patient identifiers. | Full chronological records, lab results, multi-planar DICOM imaging (MRI, CT, US). |
| **Database & Schema Isolation** | Dedicated isolated database schema; zero cross-table joins to identifiable records. | Isolated encrypted EU patient vault with separate KMS key hierarchy and consultation-scoped access roles. |
| **Consultation Deliverable** | Signed peer-to-peer consultation summary delivered directly to the treating physician. | Comprehensive written specialist opinion + Treating-Physician Handover Brief for shared care. |
| **Clinical Responsibility** | 100% retained by the local treating physician and hospital surgical team. | Sub-specialist delivers an advisory second opinion; local hospital executes treatment. |
| **EU Data Residency** | EU Regions exclusively (Frankfurt / Prague). Content never logged in LLM plain-text caches. | EU Regions exclusively (Frankfurt / Prague). At-rest AES-256 encryption with customer-scoped CMK. |

---

## 5. Frequently Asked Questions (FAQ)

### Q1: What is Clarivius — is it a software product, a telemedicine platform, or a medical service?
**Answer**: Clarivius is a Global Clinical Consultation Platform and Specialist Precedent Network. It combines a searchable Global Specialist Precedent Index with two dedicated clinical pathways: Clarivius Peer (a zero-PII doctor-to-doctor consultation platform for treating physicians and hospital departments) and Clarivius Direct (a consent-backed patient-to-specialist consultation and DICOM imaging review service).

### Q2: How does Clarivius Peer work for treating physicians and hospital departments?
**Answer**: In Clarivius Peer, a treating physician submits a structured 4-field clinical case (Age, Sex, BMI, and de-identified Clinical Narrative) in under 90 seconds. Automated privacy filters verify that zero personal identifiers are present, the Precedent Engine ranks verified global sub-specialists by documented clinical experience with that exact pathology, and the matched specialist returns a signed peer consultation summary.

### Q3: How does Clarivius Direct work for patients with complex or unresolved diagnoses?
**Answer**: In Clarivius Direct, patients submit their chronological medical history, lab results, and full multi-planar DICOM imaging (such as 3T Pelvic MRI or CT scans) under explicit per-consultation GDPR informed consent inside an isolated EU vault. Clarivius matches the dossier to a verified international sub-specialist who reviews the raw imaging and delivers a comprehensive written specialist opinion plus a Treating-Physician Handover Brief.

### Q4: Why do retrograde urethrography (UCG) and pelvic CT scans often miss Cowper's gland fistulas?
**Answer**: During retrograde urethrography (UCG), positive intraluminal contrast pressure inside the bulbar urethra frequently compresses the oblique bulbourethral duct orifice shut like a one-way flap valve, preventing contrast from entering the Cowper's gland duct and yielding a false-negative result. High-resolution 3T T2-weighted and fat-suppressed STIR pelvic MRI visualizes the mucin-filled bulbourethral gland and its fistulous tracks directly within the deep perineal pouch.

### Q5: How does Clarivius ensure GDPR compliance and separation between anonymised and identifiable data?
**Answer**: Clarivius enforces hard architectural isolation between its two pathways. Clarivius Peer processes only four non-identifiable clinical parameters (Age, Sex, BMI, Clinical Narrative) with automated PII blocking. Clarivius Direct processes identifiable records and DICOM imaging in a completely separate database schema, encryption key hierarchy, and role boundary hosted in the European Union under explicit GDPR Art. 6 and Art. 9 consent.

### Q6: Does Clarivius use AI to diagnose patients or replace the treating physician?
**Answer**: No. Software and AI components on Clarivius are strictly restricted to case structuring, personal-identifier blocking, and specialist precedent indexing. They never generate medical diagnoses or treatment recommendations. Every clinical consultation is authored by a verified human sub-specialist and is designed to support the patient's local treating physician.

### Q7: What geographic markets does Clarivius serve?
**Answer**: Clarivius is global-first by design. The specialist precedent network indexes top sub-specialists worldwide (UK, DACH, Italy, Benelux, North America). Commercial market entry begins in Europe, with pilot hospital onboarding centered in the Czech Republic and Germany.

---

## 6. Contact & Consultation Access
- Official Website: https://clarivius.com
- Clinical Desk: clinical@clarivius.com
- Data Protection & Governance: dpo@clarivius.com
- Institutional Access: https://clarivius.com/#hero
- Machine-Readable Profiles:
  - https://clarivius.com/llms.txt
  - https://clarivius.com/index.md
  - https://clarivius.com/sitemap.xml